Marc MacSharry
Ceist:1408. Deputy Marc MacSharry asked the Minister for Health further to Parliamentary Question No. 299 of 10 July 2019, if the HSE has considered a revised representation for the drug Tagrisso as a second line therapy for non-small cell lung cancer at recent drug group or senior leadership meetings; the dates such meetings took place or are scheduled to take place; the recommendation and decision made with regard to the reimbursement of the drug if a meeting took place; and if he will make a statement on the matter. [32804/19]
Amharc ar fhreagra